| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1146/ANNUREV.GENOM.2.1.463 |
| P698 | PubMed publication ID | 11701658 |
| P2093 | author name string | Balling R | |
| P304 | page(s) | 463-492 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Annual Review of Genomics and Human Genetics | Q567360 |
| P1476 | title | ENU mutagenesis: analyzing gene function in mice | |
| P478 | volume | 2 |
| Q35729853 | A genetic screen for modifiers of the delta1-dependent notch signaling function in the mouse |
| Q36319732 | A new Otogelin ENU mouse model for autosomal-recessive nonsyndromic moderate hearing impairment |
| Q34031998 | An ENU-induced mutation of Nrg1 causes dilated pupils and a reduction in muscarinic receptors in the sphincter pupillae |
| Q34170436 | An N-ethyl-N-nitrosourea (ENU)-induced dominant negative mutation in the JAK3 kinase protects against cerebral malaria |
| Q46820434 | Analysis of the MCMV resistome by ENU mutagenesis |
| Q35586667 | Behavioural screening in mutagenised mice—in search for novel animal models of psychiatric disorders |
| Q37519864 | Bioinformatical assay of human gene morbidity |
| Q36425334 | Cause and effect considerations in diagnostic pathology and pathology phenotyping of genetically engineered mice (GEM). |
| Q48273940 | Cre-mediated recombination in the skin melanocyte lineage. |
| Q37307593 | Creating a "hopeful monster": mouse forward genetic screens |
| Q27002466 | Dissecting immunity by germline mutagenesis |
| Q34736706 | Does p53 affect organismal aging? |
| Q44360084 | Drug discovery perspective of chemical-driven mouse mutagenesis |
| Q46679649 | ENU mutagenesis in mice |
| Q46976638 | Estimating the number of coding mutations in genotypic- and phenotypic-driven N-ethyl-N-nitrosourea (ENU) screens |
| Q46758970 | Evidence from the stop-EGFP mouse supports a niche-sharing model of epidermal proliferative units |
| Q41142895 | From mouse genetics to systems biology |
| Q35155809 | Functional genomics of sleep. |
| Q40137790 | Gene-environment interactions in a mutant mouse kindred with native airway constrictor hyperresponsiveness |
| Q28302668 | Genetic dissection of innate immunity to infection: the mouse cytomegalovirus model |
| Q35963838 | Genetics of dark skin in mice |
| Q90162297 | Genomic Mutation Identification in Mice Using Illumina Sequencing and Linux-Based Computational Methods |
| Q30461478 | Glycine receptor mutants of the mouse: what are possible routes of inhibitory compensation? |
| Q30839342 | High-throughput mouse knockouts provide a functional analysis of the genome |
| Q52105638 | Hox in hair growth and development |
| Q28589778 | Identification of a novel point mutation of mouse proto-oncogene c-kit through N-ethyl-N-nitrosourea mutagenesis |
| Q24808964 | Identification of cardiac malformations in mice lacking Ptdsr using a novel high-throughput magnetic resonance imaging technique |
| Q46717321 | Identification of mutations from phenotype-driven ENU mutagenesis in mouse chromosome 7. |
| Q34021005 | Identifying novel genes for atherosclerosis through mouse-human comparative genetics |
| Q45865309 | In vivo high-efficiency transcoronary gene delivery and Cre-LoxP gene switching in the adult mouse heart |
| Q36052347 | Inferring somatic mutation rates using the stop-enhanced green fluorescent protein mouse |
| Q35169902 | Integrative physiology and functional genomics of epithelial function in a genetic model organism. |
| Q30421639 | Interrogating congenital heart defects with noninvasive fetal echocardiography in a mouse forward genetic screen |
| Q34310201 | MGMT: its role in cancer aetiology and cancer therapeutics |
| Q29619081 | Mammalian circadian biology: elucidating genome-wide levels of temporal organization |
| Q35193734 | Maneuvering for advantage: the genetics of mouse susceptibility to virus infection. |
| Q36202981 | Mouse behavioural analysis in systems biology |
| Q37164126 | Mouse forward genetics in the study of the peripheral nervous system and human peripheral neuropathy |
| Q50894494 | Neurobehavioral mutants identified in an ENU-mutagenesis project. |
| Q28512079 | Nmf11 is a novel ENU-induced mutation in the mouse glycine receptor alpha 1 subunit |
| Q33490601 | Novel ENU-induced point mutation in scavenger receptor class B, member 1, results in liver specific loss of SCARB1 protein |
| Q38513138 | Ontologies for the description of mouse phenotypes |
| Q52553055 | Paradigms for the identification of new genes in motor neuron degeneration. |
| Q36039949 | Phenotype-first screening for the identification of novel drug targets |
| Q37065225 | Point mutation of Hoxd12 in mice. |
| Q48515873 | Progress in using mouse inbred strains, consomics, and mutants to identify genes related to stress, anxiety, and alcohol phenotypes |
| Q35053230 | Random mutagenesis in the mouse as a tool in drug discovery |
| Q46898473 | Spatiotemporal gene control by the Cre-ERT2 system in melanocytes |
| Q52598783 | Taking stock of our models: the function and future of stock centres. |
| Q30474232 | The clinical implications of mouse models of enhanced anxiety. |
| Q33388684 | The expanding role of mouse genetics for understanding human biology and disease |
| Q28586941 | The mouse genomic instability mutation chaos1 is an allele of Polq that exhibits genetic interaction with Atm |
| Q91212051 | The virtuous cycle of human genetics and mouse models in drug discovery |
| Q28588459 | Three ENU-induced neurological mutations in the pore loop of sodium channel Scn8a (Na(v)1.6) and a genetically linked retinal mutation, rd13 |
| Q36748513 | Three novel pigmentation mutants generated by genome-wide random ENU mutagenesis in the mouse |
| Q35405167 | Time-dependent toxic effects of N-ethyl-N-nitrosourea on the testes of male C57BL/6J mice: a histological and ultrastructural study |
| Q36762503 | Towards a compendium of essential genes - From model organisms to synthetic lethality in cancer cells |
| Q37478081 | Towards better mouse models: enhanced genotypes, systemic phenotyping and envirotype modelling |
| Q35857282 | Unraveling the genetics of chronic kidney disease using animal models |
| Q24805747 | Using ontologies to describe mouse phenotypes |
| Q34578774 | Welfare issues of genetically modified animals |
| Q28591574 | Wnk1 kinase deficiency lowers blood pressure in mice: A gene-trap screen to identify potential targets for therapeutic intervention |
Search more.